Advertisement

Press Releases

Sign up to receive press releases via email.

Press Releases

Vaping update: 2019 outbreak of lung disease associated with e-cigarettes
October 20, 2019 - The update will include a brief introduction to e-cigarette product usage and associated exposures, an overview of the CDC response to the outbreak and CDC resources, lessons learned from sentinel case clusters reported from Wisconsin/Illinois and North Carolina and results of recent toxicological research identifying effects of e-cigarette exposures on pulmonary lipid homeostasis and innate immunity.
Old school blood pressure medication prevent COPD exacerbations
October 20, 2019 - Acute chronic obstructive pulmonary disease (COPD) exacerbations may be reduced by beta-blockers, a medication widely used to treat heart failure and high blood pressure, according to a featured trial released in the New England Journal of Medicine.
Further restricting blood transfusions guidelines could save lives and money
October 14, 2019 - Blood transfusion guidelines may require further evaluation with an eye to reducing transfusions for patients with stable blood pressure.
Combination drug therapy using macitentan and tadalafil for pulmonary arterial hypertension provides clear benefits
October 14, 2019 - Patients newly diagnosed with pulmonary arterial hypertension (PAH) treated with macitentan and tadalafil combination therapy showed hemodynamic progress, as well as improvements in function and risk profile.
Aclidinium is safe and reduces COPD flare-ups, regardless of recent exacerbations
October 14, 2019 - The long-acting bronchodilator aclidinium bromide (AB) is safe for patients at increased risk for heart attack and stroke and reduces the risk of new exacerbations in people with chronic obstructive pulmonary disease (COPD), regardless of whether they have had an exacerbation in the preceding year.
See all >
Advertisement